HealthySole PLUS uses powerful UVC light to destroy up to 99.99% of pathogens on shoe soles
By 2026 we project $390 million in US revenue with 15% market share, and up to $250 million in European revenue.
We’re already generating sales in 3 core markets: long-term care, first responders, and healthcare facilities.
Over 900,000 people each year contract infections while in hospital, costing hospitals $55 Billion. Pathogens like E.Coli and MRSA spread via shoe soles, increasing the risk of hospital-acquired infections.
562% revenue growth is just the beginning
Build sales team to address high volume of clients
Expand into Europe for additional $250 million in 3 years
Partner with additional worldwide distributors
Optimize for more cost-effective production